PRTC
PureTech Health PLC
NASDAQ: PRTC · HEALTHCARE · BIOTECHNOLOGY
$17.40
-4.08% today
Updated 2026-04-29
Market cap
$441.56M
P/E ratio
10.67
P/S ratio
69.09x
EPS (TTM)
$1.70
Dividend yield
—
52W range
$15 – $20
Volume
0.0M
PureTech Health PLC (PRTC) Financial statements
SEC filings — annual and quarterly data.
Profit margin
793.00%
Operating margin
-2,590.00%
ROE
9.44%
ROA
-13.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | $7.93M | $-11.05M | 100.00% | -118.32% | -139.36% |
| 2013 | $7.02M | $-4.30M | 100.00% | -53.16% | -61.31% |
| 2014 | $2.01M | $-41.64M | 100.00% | -867.05% | -2,069.73% |
| 2015 | $11.74M | $-39.39M | 93.70% | -371.74% | -335.55% |
| 2016 | $4.43M | $-48.79M | 64.57% | -1,668.45% | -1,101.15% |
| 2017 | $650000.00 | $30.87M | -10,828.46% | -17,756.92% | 4,749.08% |
| 2018 | $16.37M | $-43.65M | -372.80% | -635.39% | -266.65% |
| 2019 | $8.69M | $421.14M | -888.12% | -1,558.46% | 4,847.42% |
| 2020 | $8.34M | $5.99M | 100.00% | -1,433.05% | 71.75% |
| 2021 | $9.98M | $-60.56M | -1,007.03% | -1,505.98% | -606.85% |
| 2022 | $2.09M | $-50.35M | -6,546.17% | -9,464.45% | -2,409.33% |
| 2023 | $3.33M | $-65.70M | -48.14% | -4,390.36% | -1,972.88% |
| 2024 | $4.83M | $53.51M | 26.04% | -2,818.87% | 1,108.33% |